By Kuldip K. Ambastha
The stock of Teladoc Health, Inc. (TDOC), a multinational virtual healthcare and telemedicine company, dropped by -40.2% per share on Thursday, April 28, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of April 26-30, 2021; By Kuldip K. Ambastha.”) Wall Street did not like the information Teladoc announced as part of the latest quarter’s performance announcement. Some items of concern were a $6.6 billion impairment charge to goodwill, lower than expected sales, slowing growth, and decreased revenue guidance for the year. The end result was a $41.58 earnings per share (EPS) loss, which was significantly more negative than what any equity research analyst was expecting for the last quarter.
Keywords – Teladoc Health, Inc., Teladoc Health, Teladoc, multinational, virtual, healthcare, telemedicine, health solutions, Wall Street, equity research, quarter, year, goodwill, impairment, sales, growth, revenue, guidance, earnings per share, EPS, loss.
Disclosure – The principals of Ambastha Financial LLC have a short position in TDOC. The clients of Ambastha Financial LLC have no positions in TDOC.
Disclaimer – No recommendations are being made via this post. Past performance is not an indicator of future performance. As an investor, you should do your own research and seek professional advice from a Registered Investment Adviser (RIA). You can lose money by investing in stocks and other instruments. Ambastha Financial LLC does not assume any responsibility (legal or otherwise) for any losses that may occur as a result of actions taken based on this post. All content copyrighted © 2022 – Ambastha Financial LLC.
CONTACT US